Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
9
×
deals
9
×
life sciences
9
×
national blog main
boston
boston blog main
clinical trials
boston top stories
fda
investing
national top stories
startups
san francisco blog main
roche
san francisco top stories
drugs
europe blog main
medical device
new york blog main
novartis
480 biomedical
achaogen
acquisitions
adams street partners
advanced therapies
akouos
allosteric
antibiotics
arsenal medical
astellas pharmaceuticals
atlas venture
atmp
atopic dermatitis
autoimmune disorders
avexis
azacitidine
beta lactamase inhibitor
beta-thalassemia
biofourmis
biomedical advanced research and development authority (barda)
What
therapeutics
9
×
medicines
developing
disease
drug
new
therapy
treat
biopharma
biotech
company
deal
fda
gene
ipo
million
raised
startup
access
address
adds
advanced
affects
ago
aims
allosteric
americans
analytics
approach
approval
approved
bacteria
based
betting
billion
biofourmis
building
business
called
capacity
Language
unset
Current search:
therapeutics
×
deals
×
biotech
×
" life sciences "
×
@xconomy.com
4 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed